Chemotherapy patients experiencing neuropathic pain may find relief from cannabis, according to a new study published last month.
The study, which was published in last month’s issue of the journal Therapeutic Advances in Medical Oncology, comes via a team of Tel Aviv-based researchers who examined a cohort of 513 patients who were taking oxaliplatin for gastrointestinal issues. Oxaliplatin, the researchers said, “is a platinum-based chemotherapy widely used for the treatment of gastrointestinal (GI) malignancies.” According to the Mayo Clinic, it is used “along with other medicines (eg, fluorouracil, leucovorin) to treat advanced cancer of the colon or rectum,” while also being “used to treat severe colon cancer in patients who have had a surgery.”
The Israeli research team said that chemotherapy-induced peripheral neuropathy is “a well-known toxicity associated with the treatment of oxaliplatin,” which “has a strong impact on the quality of life of cancer patients.”
“Acute oxaliplatin-induced neuropathy is evident in up to 90% of oxaliplatin-treated patients, and continued exposure may lead to severe chronic neuropathy in approximately 31%,” they said.
The Method and Results of the Study
For the study, the researchers treated 248 of the patients in the cohort with cannabis, with the remaining 265 serving as